GSK raises £885.6m from Haleon share sale
GSK
1,705.00p
17:14 01/05/24
1.91%
32.00p
GSK said on Friday that it has sold 270m shares in Haleon - the consumer health business it spun off last year - raising around £885.6m.
FTSE 100
8,121.24
16:49 01/05/24
n/a
n/a
FTSE 350
4,464.43
17:14 01/05/24
n/a
n/a
FTSE All-Share
4,418.60
16:54 01/05/24
n/a
n/a
Haleon
331.00p
16:49 01/05/24
-2.50%
-8.50p
Pharmaceuticals & Biotechnology
23,158.72
17:14 01/05/24
0.83%
190.21
The company sold the shares in a placing to institutional investors at 328p each.
Following the settlement of the placing, GSK will hold 685m ordinary shares in Haleon, which represents a stake of 7.4%.
GSK and Pfizer, which has a 32% interest in Haleon, have each undertaken not to dispose of any further shares in Haleon for 60 days following settlement of the placing.